Skip to main content

Table 1 Pre-study signalment and morphometric measurements (mean ± SE, or median and range) of ponies enrolled in a study on the effects of velagliflozin

From: The efficacy and safety of velagliflozin over 16 weeks as a treatment for insulin dysregulation in ponies

Measure

Control

Treated

P value

Age (yr)

16.03 ± 1.03

15.4 ± 1.4

0.709

Height (in)

42.3 ± 2.4

41.2 ± 2.4

0.748

Weight (kg)

227 ± 41

217 ± 22

0.291

Sex

8 F, 4 M

6 F, 6 M

0.408

BCSa

7 (6–9)

7 (6–9)

0.937

CNSb

3 (3–5)

3 (2–5)

0.808

n

12

12

 
  1. aBCS: Body Condition Score
  2. bCNS: Cresty Neck Score